NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Dr. Reddy s Laboratories Limited (NSE: DRREDDY)
DRREDDY Technical Analysis
2
As on 19th Apr 2024 DRREDDY SHARE Price closed @ 5942.85 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5595.27 & Strong Sell for SHORT-TERM with Stoploss of 6217.26 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DRREDDYSHARE Price
Open | 6000.00 | Change | Price | % |
High | 6000.00 | 1 Day | -14.30 | -0.24 |
Low | 5880.80 | 1 Week | -141.00 | -2.32 |
Close | 5942.85 | 1 Month | -192.05 | -3.13 |
Volume | 342651 | 1 Year | 1033.50 | 21.05 |
52 Week High 5953.35 | 52 Week Low 3880.00 |
DRREDDY CURRENT MONTH FUTURE | |||
Close | 5926.00 | ||
Contracts Traded | 597500 | ||
Open Intrest | 2069125 | ||
Change In O.I | -5.83 % | ||
Lot Size | 125 |
DRREDDY CURRENT MONTH OPTION | |
Most Active Call | 6000.00 |
Most Active put | 5800.00 |
Highest O.I Buildup Call | 6200.00 |
Highest O.I Buildup Put | 6100.00 |
Expiry Date | 2024-04-25 |
DRREDDY ALL MONTHS OPTIONS | |||
For All DRREDDY Options Click Here |
NSE INDIA Most Active Stocks
IDEA | 12.90 | -2.27% |
YESBANK | 23.95 | 0.21% |
GTLINFRA | 1.75 | 0.00% |
NHPC | 87.15 | -2.63% |
TATASTEEL | 162.10 | 1.28% |
SUZLON | 39.35 | -4.37% |
INDUSTOWER | 351.40 | 2.03% |
PNB | 128.25 | -1.00% |
SAIL | 146.05 | 0.86% |
ZOMATO | 189.20 | 2.16% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
EXCEL | 0.50 | -9.09% |
ANMOL | 42.25 | -7.85% |
SHARDAMOTR | 1504.15 | -5.41% |
TATACOMM | 1755.20 | -5.33% |
JUBLPHARMA | 665.00 | -5.09% |
ARENTERP | 52.10 | -5.01% |
PVP | 31.30 | -5.01% |
PVP | 31.30 | -5.01% |
ARVEE | 237.35 | -5.00% |
GKWLIMITED | 2531.05 | -5.00% |
DRREDDY Daily Charts |
DRREDDY Intraday Charts |
Whats New @ Bazaartrend |
DRREDDY Free Analysis |
|
DRREDDY Important Levels Intraday
RESISTANCE | 6172.55 |
RESISTANCE | 6098.88 |
RESISTANCE | 6053.35 |
RESISTANCE | 6007.81 |
SUPPORT | 5877.89 |
SUPPORT | 5832.35 |
SUPPORT | 5786.82 |
SUPPORT | 5713.15 |
DRREDDY Target April 2024
4th UP Target | 8092.13 |
3rd UP Target | 7483.24 |
2nd UP Target | 7106.88 |
1st UP Target | 6730.51 |
1st DOWN Target | 5656.59 |
2nd DOWN Target | 5280.22 |
3rd DOWN Target | 4903.86 |
4th DOWN Target | 4294.97 |
DRREDDY Weekly Target
4th UP Target | 6581.69 |
3rd UP Target | 6422.03 |
2nd UP Target | 6323.34 |
1st UP Target | 6224.65 |
1st DOWN Target | 5943.05 |
2nd DOWN Target | 5844.36 |
3rd DOWN Target | 5745.67 |
4th DOWN Target | 5586.01 |
DRREDDY Target2024
4th UP Target | 9637.83 |
3rd UP Target | 8406.34 |
2nd UP Target | 7645.13 |
1st UP Target | 6883.92 |
1st DOWN Target | 4711.88 |
2nd DOWN Target | 3950.67 |
3rd DOWN Target | 3189.46 |
4th DOWN Target | 1957.97 |
Dr. Reddy s Laboratories Limited ( NSE INDIA Symbol : DRREDDY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DRREDDY Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is Below 30 | Over Sold | |
MFI (14) | MFI is 26.90 | Sideways | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 3152.68 | |
10 Day Avg Volume | Traded -18.28 % Less then 10 Day Average Volume |
DRREDDY Other Details
Segment | EQ | |
Market Capital | 777352314880.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
DRREDDY Address
DRREDDY Latest News
DRREDDY Business Profile
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and commercialization of differentiated formulations for dermatology and neurology therapeutic areas. The Others segment engages in developing therapies in the fields of oncology and inflammation. As of March 31, 2021, it had three late stage projects at various stages of development. Its therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Address: 8-2-337, Road No. 3, Hyderabad, India, 500034
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service